Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Circulation|February 24, 2017
Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])Ratika Parkash, George A Wells, John L Sapp, et al.
Circulation. Heart Failure|August 17, 2012
Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT)Jeff S Healey, Stefan H Hohnloser, Derek V Exner, et al.
Circulation|March 22, 2022
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trialRatika Parkash, George A Wells, Jean Rouleau, et al.
The New England Journal of Medicine|June 23, 2006
Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillationMichael H Gollob, Douglas L Jones, Andrew D Krahn, et al.
Circulation. Arrhythmia and Electrophysiology|November 25, 2014
Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudyVidal Essebag, Jacqueline Joza, David H Birnie, et al.
Journal of the American College of Cardiology|November 11, 2025
Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia: A Substudy of the VANISH2 TrialPablo B Nery, George A Wells, Anthony S L Tang, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 18, 2025
Long-term all-cause mortality and hospitalizations after catheter ablation in patients with paroxysmal and persistent atrial fibrillationChristopher C Cheung, Feng Qiu, Olivia Haldenby, et al.
Journal of Cardiovascular Electrophysiology|January 10, 2018
Quality of life with ablation or medical therapy for ventricular arrhythmias: A substudy of VANISHLorne J Gula, Steve Doucette, Peter Leong-Sit, et al.
The New England Journal of Medicine|January 17, 2024
Long-Term Outcomes of Resynchronization-Defibrillation for Heart FailureJohn L Sapp, Soori Sivakumaran, Calum J Redpath, et al.
The New England Journal of Medicine|May 6, 2016
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic DrugsJohn L Sapp, George A Wells, Ratika Parkash, et al.
Pageof 17